Response Biomedical Corporation (TSX: RBM CN)

Response Biomedical Corporation (TSX: RBM CN) is focused on developing, manufacturing, and marketing rapid on-site diagnostic tests designed to be used with its RAMP(R) Platform for clinical and environmental applications. The company’s novel platform represents a new paradigm in diagnostics that advantageously provides high sensitivity and dependable information in moments. The RAMP system potentially could be applied to over 250 medical and non-medical tests currently performed in laboratories. For further information, visit the Company’s web site at www.responsebio.com.